Clinical usefulness of iodine-123-MIBG scintigraphy for patients with neuroblastoma detected by a mass screening survey

Annals of Nuclear Medicine

Volumn 17, Issue 8, 2003, Pages 633-640

  Hashimoto, Tsuyoshi ^a   Koizumi, Kiyoshi ^a   Nishina, Takako ^b   Abe, Kimihiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b Tokyo Metropol Hachioji Child H ^*  (Japan)

Author keywords

Iodine 123 MIBG; Mass screening; Neuroblastoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; HOMOVANILLIC ACID; LACTATE DEHYDROGENASE; NEURON SPECIFIC ENOLASE; TUMOR MARKER; VANILMANDELIC ACID;

ARTICLE; BLOOD ANALYSIS; BONE MARROW METASTASIS; BRAIN SCINTISCANNING; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HUMAN; INFANT; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; MASS SCREENING; NEUROBLASTOMA; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; URINALYSIS; WHOLE BODY SCINTISCANNING;

EID: 1042279675     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02984968     Document Type: Article

References (19)

1. Sawada T. Past and future of neuroblastoma screening in Japan. American Journal of Pediatric Hematology-Oncology 1992; 14: 320-326.
2. Sawada T. Outcome of 25 neuroblastomas revealed by screening in Japan. Lancet 1986; 1: 377.
3. 123I-metaiodobenzylguanidine (MIBG) scintigraphy for the staging of neuroblastoma. KAKU IGAKU (Jpn J Nucl Med) 1998; 35: 835-842.
4. Gelfand MJ, Elgazzar AH, Kriss VM, Masters PR, Golsch GJ. Iodine-123-MIBG SPECT versus planar imaging in children with neural crest tumors. J Nucl Med 1994; 35: 1753-1757.
5. Rufini V, Fisher GA, Shulkin BL, Sisson JC, Shapiro B. Iodine-123-MIBG imaging of neuroblastoma: utility of SPECT and delayed imaging. J Nucl Med 1996; 37: 1464-1468.
6. Ikekubo K, Hino M, Ootsuka H, Ito H, Yamaguchi H, Dan Y. Detection of neural crest tumors by iodine-123-MIBG scintigraphy. KAKU IGAKU (Jpn J Nucl Med) 1994; 31: 1357-1364.
7. 123I-MIBG scintigraphy in localization of tumors of sympathetic and adrenomedullary origin - A report of multicenter phase III clinical trials. KAKU IGAKU (Jpn J Nucl Med) 2000; 37: 43-59.
8. Okuyama C, Ushijima Y, Watanabe K, Sugihara H, Nishimura T. Iodine-123-MIBG scintigraphy in neuroblastoma: relationship between the intensity of uptake and tumor characteristics. KAKU IGAKU (Jpn J Nucl Med) 1999; 36: 827-834.
9. 123I-MIBG scintigraphy in neuroblastoma: a comparison between planar and SPECT imaging. Quarterly J Nucl Med 1995; 39: 25-28.
10. Kawakami T, Monobe Y, Monforte H, Woods WG, Tuchman M, Lemieux B, et al. Pathology review of screening negative neuroblastomas: a report from the Quebec neuroblastoma screening project. Cancer 1998; 83: 575-581.
11. Nesbit ME Jr. Advances and management of solid tumors in children. Cancer 1990; 65: 696-702.
12. Ater JL, Gardner KL, Foxhall LE, Therrell BL Jr, Bleyer WA. Neuroblastoma screening in the United States: results of the Texas outreach program for neuroblastoma screening. Cancer 1998; 82: 1593-1602.
13. Bozkowa K, Cabalska B, Radomyska B, Oltarzewski M, Lenartowska I. Evaluation of the usefulness for neonatal mass screening in light of 35 years personal experience. Medycyna Wieku Rozwojowego 1999; 3: 529-559.
14. Wieland DM, Swanson DP, Brown LE, Beierwaltes WH. Imaging the adrenal medulla with an iodine-131-labeled antiadrenergic agent. J Nucl Med 1979; 20: 155-158.
15. Edeling CJ, Frederiksen PB, Kamper J, Jeppesen P. Diagnosis and treatment of neuroblastoma using metaiodobenzylguanidine. Clin Nucl Med 1987; 12: 632-637.
16. Iwahita S, Nakajo M, Nakabeppu Y, Tanoue T, Yonekura R, Taguchi M, et al. Clinical evaluation of I-131-metaiodobenzylguanidine (MIBG) imaging in suspected neuroblastoma. KAKU IGAKU (Jpn J Nucl Med) 1989; 26: 1135-1147.
17. Murashima S, Takeda K, Okuda Y, Nakagawa T, Sakurai M. Assessment of biological activity of recurrent tumor of neuroblastoma with iodine-131-metaiodobenzylguanidine (MIBG) scintigraphy. KAKU IGAKU (Jpn J Nucl Med) 1990; 27: 1393-1400.
18. Odano I, Takeda M, Kimura M, Sakai K. Clinical significance of iodine-131-metaiodobenzylguanidine scintigraphy in neuroblastoma. Nippon Act Radiol 1988; 48: 623-632.
19. Mark E, Nesbit ME Jr. Advances and management of solid tumors in children. Cancer 1990; 65: 696-702.